Lee Kalowski

CIK 1618273 · CFO and President · last filed 2026-03-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.25M

Companies

3

Total Filings

28

Lifetime Open-Market Net

-$3.05M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QTTB CFO and President 89,193 $12.64 $1.13M -$57.1K 6 2026-03-20
BCYC President and CFO 30,309 $4.05 $122.8K -$2.82M 16 2023-04-05
Eledon Pharmaceuticals, Inc. (TKAI) Delisted Chief Financial Officer 40,953 -$174.5K 6 2015-12-17

Recent Filings · Page 2 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-08-27 BCYC Mixed -$224.5K EDGAR
2021-08-25 BCYC Mixed -$235.7K EDGAR
2021-07-30 BCYC Mixed -$373.4K EDGAR
2021-01-21 BCYC Mixed -$426.1K EDGAR
2021-01-15 BCYC Mixed -$234.0K EDGAR
2021-01-05 BCYC Grant (A) $0 EDGAR
2020-12-03 BCYC Mixed -$157.1K EDGAR
2020-11-30 BCYC Mixed -$9.8K EDGAR
2020-11-25 BCYC Mixed -$495.0K EDGAR
2020-04-27 BCYC Grant (A) $0 EDGAR
Showing 1120 of 28
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.